Clinical Trial Update: Taltz in Combination With Enstilar for Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating Taltz in combination with Enstilar for psoriasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Enstilar (calcipotriene; betamethasone dipropionate)
• TALTZ (IXEKIZUMAB)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Psoriasis | Phase 4 | Status: RECRUITING